Approved for use in Europe/Asia per CE/ISO and NOT AUTHORIZED OR CLEARED FOR USE IN THE USA
Follow us on Social Media for more information on our test kits.
Corona Testing Kit

Confirmatory Real-time reverse transcription polymerase chain reaction (rRT -PCR) test 

Unparalleled linearity of 0.9929~0.9999 (Correlation coefficient; R2) in concentrations ranging from 10^2~7 copies/ul

Limit of Detection of 10~30 copies/uL even in sputum.

US patent filed/South Korea patent filed with original sequence for all molecular targets

European IVD-CE certification achieved (CMC/CE/2020/03072020.1)

ISO 13485 certified CGMP (Current Good Manufacturing Practice regulations) manufacturing process and quality management

New POC (Point of care) rapid antigen testing with unprecedented performance results

(Approved for use in Europe/Asia per CE/ISO and NOT AUTHORIZED OR CLEARED FOR USE IN THE USA)

GG COVID-19 Omicron/Delta PCR test kit

The GG COVID-19 variant RT-PCR kit enables multiplexing mutation hot spots in a singe tube to detect most (9) of the current COVID-19 variants of interest/concern including the “Delta variant” and “Omicron variant”.

GG COVID-19 variant RT-PCR kit is versatile, can be run on a variety of different PCR machines with a running time of ~2 hour (minus the nucleic acid extraction time) and LOD of ~10^1-2 cp/uL.

GG COVID-19 mutation kit may be used in the in vitro qualitative detection of COVID-19 virus variants from respiratory specimens and is the first PCR test that can differentiate Omicron variant from Delta variant versus non-Omicron, non-Delta Sars-CoV-2 (COVID-19) in a single tube.

Delta patients benefit most from the casirivimab and imdevimab (Regeneron) and Bamlanivimab(Eli Lily), while Omicron patients benefit from  sotrovimab (VIR-7831(GlaxoSmithKline and Vir Biotechnology); GG COVID-19 mutation kit has the potential to guide therapy and be used in the triage of patients.

(Approved for use in Europe/Asia per CE/ISO and NOT AUTHORIZED OR CLEARED FOR USE IN THE USA)


Variety of molecular microbiology and cancer genetics products

Cellgenemedix Good Ag Rapid COVID-19 Antigen Test & GG COVID-19 Omicron/Delta PCR study for participation in research

Grant applications for underserved communities and countries

Cellgene Medix currently developed the world's first Omicron/Delta Covid-19 PCR test which is available for sale in Europe and Asia. We are a biotech company based in the United States and South Korea with Korean FDA accredited manufacturing based in Seoul, South Korea which was cGMP certified by ISO 13485 and 9001 and CE mark. Our previous company been manufacturing and selling a number of molecular testing tools including PCR kits and DNA microarrays for the detection of infectious disease, cancer and guiding genomic information-based tailor-made treatment of infectious diseases and cancers for ~20 years. We have research facilities and hospitals where we may perform state of the art molecular studies and therapies and have achieved US and international patents and CE mark for a variety of our products.